Literature DB >> 15071777

Percutaneous bypass: subintimal recanalization of peripheral occlusive disease with IVUS guided luminal re-entry.

Ramin R Saketkhoo1, Mahmood K Razavi, Arash Padidar, Stephen T Kee, Daniel Y Sze, Michael D Dake.   

Abstract

Angioplasty of chronic total occlusions (CTOs) has lower technical success rates with longer procedure times and poorer outcomes. Subintimal recanalization remains limited by the lack of controlled re-entry into the true lumen of the target vessel. We report our experience using a commercially available catheter-based system equipped with an intravascular ultrasound scanner to achieve controlled true lumen re-entry in patients with peripheral CTOs. In a 4-month period, 6 patients with lower extremity (LE) ischemia from CTOs were treated. Occluded segments were crossed subintimally, and controlled re-entry was secured using the CrossPoint TransAccess catheter. This 6.2 F dual-lumen catheter contains an integrated 64-element phased array intravascular ultrasound scanner enabling targeting of structures. Intravascular ultrasound-guided luminal re-entry was achieved by advancing a 24-gauge needle to a desired length and delivering a 0.014" guide wire into the target lumen. The occluded segments were balloon dilated and stented using self-expanding nitinol stents. Effective luminal re-entry and re-establishment of antegrade flow occurred in all 6 patients. Time to recanalization ranged from 5 to 10 minutes. All patients were free of ischemic symptoms at 1 to 5 month follow-up. There were no procedure-related complications. Our preliminary results demonstrate the feasibility of using this catheter system for subintimal recanalization with controlled re-entry in CTOs. This approach can improve the technical success rate, reduce the time of the procedure, and minimize potential complications.

Entities:  

Mesh:

Year:  2004        PMID: 15071777     DOI: 10.1053/j.tvir.2004.01.006

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  7 in total

Review 1.  Applications of grayscale and radiofrequency intravascular ultrasound to image atherosclerotic plaque.

Authors:  Somjot S Brar; Gary S Mintz; Akiko Maehara; Gregg W Stone
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

Review 2.  [Subintimal recanalization. Indications, technique and results].

Authors:  B Radeleff; M Sumkauskaite; N Kortes; D Gnutzmann; T Mokry; H U Kauczor; U Stampfl
Journal:  Radiologe       Date:  2016-03       Impact factor: 0.635

3.  Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia between patients with and without diabetes.

Authors:  Jeremy D Darling; Thomas C F Bodewes; Sarah E Deery; Raul J Guzman; Mark C Wyers; Allen D Hamdan; Hence J Verhagen; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2017-09-22       Impact factor: 4.268

4.  Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.

Authors:  Jeremy D Darling; John C McCallum; Peter A Soden; Lindsey Korepta; Raul J Guzman; Mark C Wyers; Allen D Hamdan; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2017-03-06       Impact factor: 4.268

5.  Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia in insulin-dependent diabetic patients.

Authors:  Jeremy D Darling; Thomas F X O'Donnell; Sarah E Deery; Anthony V Norman; Giap H Vu; Raul J Guzman; Mark C Wyers; Allen D Hamdan; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2018-11       Impact factor: 4.268

Review 6.  Intravascular Ultrasound in the Endovascular Treatment of Patients With Peripheral Arterial Disease: Current Role and Future Perspectives.

Authors:  Romaric Loffroy; Nicolas Falvo; Christophe Galland; Léo Fréchier; Frédérik Ledan; Marco Midulla; Olivier Chevallier
Journal:  Front Cardiovasc Med       Date:  2020-12-02

Review 7.  [Endovascular Revascularization for Aortoiliac Occlusive Disease].

Authors:  Myungsu Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-05-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.